Cargando…
Mixed outcomes for computational predictions
Experimental efforts to validate the output of a computational model that predicts new uses for existing drugs highlights the inherently complex nature of cancer biology.
Autor principal: | Dang, Chi Van |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245956/ https://www.ncbi.nlm.nih.gov/pubmed/28100399 http://dx.doi.org/10.7554/eLife.22661 |
Ejemplares similares
-
Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer
por: Yan, Xuebing, et al.
Publicado: (2018) -
Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
por: Tan, Ping, et al.
Publicado: (2018) -
A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma
por: Sun, Xiao‐Yan, et al.
Publicado: (2020) -
Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020) -
NOTCH3 limits the epithelial–mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer
por: Matsuura, Norihiro, et al.
Publicado: (2021)